![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 2, 809-816, January 14, 2000
From the Thrombin is an allosteric protease controlled
through exosites flanking the catalytic groove. Binding of a peptide
derived from hirudin (Hir52-65) and/or of heparin to
these opposing exosites alters catalysis. We have investigated the
contribution of subsites S2' and S3' to this
allosteric transition by comparing the hydrolysis of two sets of
fluorescence-quenched substrates having all natural amino acids at
positions P2' and P3'. Regardless of the amino
acids, Hir52-65 decreased, and heparin increased the
kcat/Km value of hydrolysis
by thrombin. Several lines of evidence have suggested that
Glu192 participates in this modulation. We have examined
the role of Glu192 by comparing the catalytic activity of
thrombin and its E192Q mutant. Mutation substantially diminishes the
selectivity of thrombin. The substrate with the "best"
P2' residue was cleaved with a
kcat/Km value only 49 times
higher than the one having the "least favorable" P2'
residue (versus 636-fold with thrombin). Mutant E192Q also lost the strong preference of thrombin for positively charged P3' residues and its strong aversion for negatively charged
P3' residues. Furthermore, both Hir52-65 and
heparin increased the
kcat/Km value of
substrate hydrolysis. We conclude that Glu192 is critical
for the P2' and P3' specificities of thrombin
and for the allostery mediated through exosite 1.
The Role of Glu192 in the Allosteric Control of the
S2' and S3' Subsites of Thrombin*
,
,
, and
¶
INSERM, U428, Université Paris V,
Faculté de Pharmacie 4 Avenue de l'Observatoire, 75270 Paris
Cedex 06, France and the § Departamento de Biofisica, Escola
Paulista de Medicina, Rua Três de Maio, 100, 04044-020 São Paulo, SP, Brazil
*
This work was supported in part by INSERM of France, by the
Fondation pour la Recherche Médicale of France, and by the Accord de Coopération Biomédicale Franco-Brésilienne
(INSERM/FAPESP 1999/2000).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
A. A. Amelot, M. Tagzirt, G. Ducouret, R. L. Kuen, and B. F. Le Bonniec Platelet Factor 4 (CXCL4) Seals Blood Clots by Altering the Structure of Fibrin J. Biol. Chem., January 5, 2007; 282(1): 710 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Bianchini, V. B. Louvain, P.-E. Marque, M. A. Juliano, L. Juliano, and B. F. Le Bonniec Mapping of the Catalytic Groove Preferences of Factor Xa Reveals an Inadequate Selectivity for Its Macromolecule Substrates J. Biol. Chem., May 31, 2002; 277(23): 20527 - 20534. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |